Biochemical Markers and 2 and 3D Ultrasound to ID Maternal & Fetal Complications
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01404221
Recruitment Status :
(No safety issues. Need to rewrite protocol)
Can a combination of prenatal screening blood tests, early ultrasound, and a 3D ultrasound of the fetal face at approximately 20 weeks gestation identify fetuses with congenital anomalies and predict maternal and fetal complications?
Condition or disease
Pts will be consented upon presenting to the department for a comprehensive ultrasound.The 3D picture is the only part of the study that is not part of standard obstetrical care.
Correlation of geometric morphometric analysis of fetal brow to 10 soft markers [ Time Frame: completion of pregnancy ]
In patients who have undergone step-wise sequential screening, how often will the evaluation of 10 midtrimester sonographic soft markers of aneuploidy such that the recommendation regarding invasive diagnostic testing be changed?
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
18 Years to 50 Years (Adult)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Pregnant women presenting for a comprehensive ultrasound at approximately 20 weeks
Pregnant women at approximately 20 weeks
plans to deliver at North Shore University Hosp
completed step-wise sequential screening
patients who have undergone diagnostic genetic testing
intention to deliver at a hospital other than North Shore University hosp